Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
In Vivo (Athens, Greece)|February 28, 2024
Evaluation of Prediabetes in Cisplatin-induced Nephrotoxicity in the Short Hydration Method: A Subgroup AnalysisYoshitaka Saito, Tatsuhiko Sakamoto, Masaki Kobayashi, et al.
Scientific Reports|November 9, 2023
Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatmentYoshitaka Saito, Shinya Tamaki, Daisuke Hirate, et al.
Respiratory Investigation|January 21, 2026
A case of synchronous multiple primary lung cancers each harboring an EGFR mutation or an ALK fusion gene alone that responded to osimertinib with chemotherapyDoppo Fukui, Daisuke Morinaga, Jun Sakakibara-Konishi, et al.
Respiratory Medicine Case Reports|November 28, 2025
Rapid disease progression and hydrocephalus following tarlatamab therapy initiation: A case reportDoppo Fukui, Jun Sakakibara-Konishi, Riku Azuma, et al.
Radiation Oncology (London, England)|March 23, 2013
Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancerTetsuya Inoue, Norio Katoh, Rikiya Onimaru, et al.
Respiratory Medicine Case Reports|July 28, 2020
Nivolumab-induced immune thrombocytopenia in a patient with malignant pleural mesotheliomaJun Sakakibara-Konishi, Mineyoshi Sato, Michiko Takimoto Sato, et al.
Respiratory Investigation|November 12, 2025
Successful treatment of huntingtin-interacting protein-1-anaplastic lymphoma kinase-positive lung cancer with severe airway stenosis using silicone stent placement and alectinibYuma Sato, Hidenori Kitai, Yuta Takashima, et al.
In Vivo (Athens, Greece)|October 30, 2024
Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor MonotherapyAtsushi Yamaguchi, Yoshitaka Saito, Keisuke Okamoto, et al.
Japanese Journal of Radiology|September 12, 2025
Association between FDG accumulation in interstitial lesions and acute exacerbation risk in lung cancer: multicenter analysisYuriko Ishida, Shiro Watanabe, Jun Sakakibara-Konishi, et al.
Lung Cancer (Amsterdam, Netherlands)|August 29, 2012
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cellsJunko Kikuchi, Taichi Takashina, Ichiro Kinoshita, et al.
Pageof 10